Health Care

Sanofi Boosts Alzheimer's Pipeline With Vigil Neuroscience Acquisition

Health Care Stocks Like UnitedHealth, CVS Tank On Wednesday: Here's Why

What's Going On With UroGen Pharma Stock Wednesday?

Health Care Stocks Like UnitedHealth, CVS Tank On Wednesday: Here's Why

What's Going On With UroGen Pharma Stock Wednesday?

EXCLUSIVE: Telomir Pharma To Raise $3 Million Via Equity Financing To Fund Its Rare Disease IND

Bicara Therapeutics Shares Sink Over 43% On Mixed Phase 1/1b Trial Results: What's Going On?

EXCLUSIVE: Telomir Pharma To Raise $3 Million Via Equity Financing To Fund Its Rare Disease IND

Bicara Therapeutics Shares Sink Over 43% On Mixed Phase 1/1b Trial Results: What's Going On?

WallStreetBets Redditor Says He Dropped $100K Into UnitedHealth After Selling His House Without Telling His Wife: 'Hold My Beer'

Elizabeth Warren Says Jeff Bezos And Elon Musk 'Are Popping Champagne' As House Passes Trump's 'Big, Beautiful Bill' She Calls A Handout To Billionaires

Health Care Recent News

Frank Bisignano Had To Google Social Security When He First Got A Call For The Job: 'What The Heck's The Commissioner…'

New Social Security Commissioner Frank Bisignano, with no prior government experience, plans to modernize the agency and assure its longevity.

RFK Jr.'s 'Make America Healthy Again' Report Stirs GOP, Farmers Over Glyphosate Concerns Ahead Of Release

Robert F. Kennedy Jr. faces mounting pressure from Republican lawmakers and farming communities as his highly anticipated "Make America Healthy Again" report approaches Thursday's release.

House Advances Trump's 'One Big Beautiful Bill' After Key Medicaid, Tax, And Border Security Changes

The House Rules Committee advanced President Trump's "One Big Beautiful Bill Act" in an 8-4 vote following a marathon 22-hour hearing.

FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr.

The U.S. Food and Drug Administration has announced significant changes to COVID-19 vaccine requirements, limiting annual booster approvals to older and high-risk Americans while implementing stricter clinical trial requirements for healthy adults.

Trump's Tax Bill Expands Child Benefits With $2,500 Credit And $1,000 Savings Boost For Babies Born Through 2028

Trump's proposed 1,000-page bill could increase tax credits for parents and introduce savings accounts for children.

Pfizer Secures Global Rights To China's 3SBio's Cancer Drug In $6 Billion Deal

Pfizer Inc. announced Monday it has secured exclusive global rights, excluding China, to 3SBio Inc.'s bispecific antibody SSGJ-707.

Trump's 'Big Beautiful Bill' Advances: Here's Who Wins And Loses

Trump's sweeping tax-and-spending bill stirs markets, boosts defense, hits clean energy, and expands debt.

Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal

Regeneron (REGN) to acquire 23andMe for $256 million, plans to maintain consumer services and uphold privacy policies. Deal expected to close Q3 2025.

GoodRx Offers Value Proposition As Pharmacy Costs Shifts To Consumers: Analyst

J.P. Morgan analyst revises outlook on GoodRx Holdings following Q1 earnings, reaffirms Overweight rating and $7 price target.

EXCLUSIVE: UnitedHealth Gets Dumped, Why This Asset Manager Says Insurer Is No Longer A Safe Bet

Asset manager dumps UNH stock, citing deterioration in fundamentals and turns to innovation-driven segments and global insurance firms. The focus now is on innovation, not incumbency.

EXCLUSIVE: GT Biopharma Advances Relapsed Blood Cancer Therapy Trial To Cohort 2 After Promising Early Safety Results

GTBP announces completion of dosing in Cohort 1 and start of dosing in Cohort 2 of Phase 1 trial for GTB-3650, showing potential for NK cell expansion and increased immunologic activity. Detailed results to be released in 2025. GTBP stock up 0.90%.

Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety Scrutiny

The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.'s COVID-19 vaccine, restricting its use to people 65 and older and those 12 and up with underlying health conditions that increase risk of severe illness.

Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion

Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come under scrutiny for opaque pricing practices. Mark Cuban calls PBMs a racket.